Careers
Contact
News
About
Product Pipeline
XEN1101 (FOS)
XEN1101 (PGTCS)
XEN1101 (MDD)
NBI-921352 (Neurocrine)
Investors
Investor Overview
Stock Quote
Stock Chart
Historic Stock Lookup
Analyst Coverage
News & Events
Press Releases
Events Calendar
Corporate Governance
Management
Board of Directors
Committee Composition
Financials & Filings
Annual Financial Reports
Quarterly Results
Contact Investor Relations
Partners
Medical Affairs
Publications
Expanded Access Program
About
Product Pipeline
Investors
Partners
Medical Affairs
Careers
Contact
News
XEN1101 Phase 3 Program is Launched!
Two identical Phase 3 clinical trials evaluating XEN1101 in patients with focal onset seizures
A Phase 3 clinical trial evaluating XEN1101 in patients with primary generalized tonic-clonic seizures
